Sertraline and Cognitive Therapy in Depressed Alcoholics
Status:
Completed
Trial end date:
2002-01-01
Target enrollment:
Participant gender:
Summary
This study will assess whether individuals treated with sertraline (Zoloft) and cognitive
behavior therapy will experience improvement with their depression and consume less alcohol
than individuals treated with a placebo and cognitive behavior therapy. This is a 12-week,
random assignment, placebo-controlled, double-blind study with followup assessments 1 and 3
months after treatment.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)